Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Drug repurposing finds new uses for old drugs quickly and cheaply.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Genetic factors can predict male pattern baldness risk.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The ABCG2 gene variant increases the risk of high uric acid and cholesterol, especially in overweight or obese young Mexican males.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The ethanol patch test reliably identifies ALDH phenotype.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Some women with PCOS have rare genetic variants linked to the condition.

PCOS shares similar genetic traits across different diagnosis criteria and is linked to other health conditions.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

New method measures finasteride in blood quickly and accurately.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

Using electronic health records can help identify drug side effects but has some limitations.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

MicroRNAs could help assess and manage multiple chronic diseases.

New technologies replicate human skin for testing without animals.